SCHEMBL7936347

SCHEMBL7936347

CCCNCCC1CCC(NC(=O)c2ccc(-c3ccccn3)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 2/20 0.50
▸ MEN1 O00255 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ TRPV1 Q8NER1 2/20 0.46
▸ TTK P33981 3/20 0.45
▸ MAPK14 Q16539 2/20 0.44
▸ TGFBR1 P36897 1/20 0.44
▸ HPGDS O60760 1/20 0.44
▸ RIPK1 Q13546 1/20 0.43
▸ MAPK11 Q15759 1/20 0.43
▸ CYP46A1 Q9Y6A2 1/20 0.43
▸ GABRA5 P31644 1/20 0.43
▸ SMYD3 Q9H7B4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12523886 0.85 DRD2 (0.57) DRD2MEN1NPC1RAB9AKMT2A
SCHEMBL14082199 0.84 MEN1 (0.65) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL14082175 0.80 TRPV1 (0.54) DRD2MEN1NPC1RAB9AKMT2A
SCHEMBL14082198 0.79 GRM5 (0.58) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL14082162 0.78 GRM5 (0.57) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL21477359 0.77 TRPV1 (0.53) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL14082232 0.77 ATR (0.58) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL14082178 0.76 HPGDS (0.61) DRD2MEN1NPC1RAB9AKMT2A
SCHEMBL13181085 0.75 MEN1 (0.58) DRD2MEN1NPC1RAB9AKMT2A
SCHEMBL228988 0.74 DRD2 (0.58) DRD2HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010025235-A1 SELECTIVE LIGANDS FOR THE DOPAMINE 3 (D3) RECEPTOR AND METHODS OF USING THE SAME REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-03-04 — — WO disclosed
Send feedback